IRIS Accounts Production v24.1.0.578 11925469 Board of Directors 1.5.22 30.4.23 30.4.23 false true false false false true false Ordinary 0.01000 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119254692022-04-30119254692023-04-30119254692022-05-012023-04-30119254692021-04-30119254692021-05-012022-04-30119254692022-04-3011925469ns15:EnglandWales2022-05-012023-04-3011925469ns14:PoundSterling2022-05-012023-04-3011925469ns10:Director12022-05-012023-04-3011925469ns10:PrivateLimitedCompanyLtd2022-05-012023-04-3011925469ns10:SmallEntities2022-05-012023-04-3011925469ns10:AuditExempt-NoAccountantsReport2022-05-012023-04-3011925469ns10:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-3011925469ns10:SmallCompaniesRegimeForAccounts2022-05-012023-04-3011925469ns10:FullAccounts2022-05-012023-04-301192546912022-05-012023-04-3011925469ns10:OrdinaryShareClass12022-05-012023-04-3011925469ns10:OrdinaryShareClass1112022-05-012023-04-3011925469ns10:Director32022-05-012023-04-3011925469ns10:Director42022-05-012023-04-3011925469ns10:Director52022-05-012023-04-3011925469ns10:Director72022-05-012023-04-3011925469ns10:Director82022-05-012023-04-3011925469ns10:Director92022-05-012023-04-3011925469ns10:Director112022-05-012023-04-3011925469ns10:RegisteredOffice2022-05-012023-04-3011925469ns5:CurrentFinancialInstruments2023-04-3011925469ns5:CurrentFinancialInstruments2022-04-3011925469ns5:Non-currentFinancialInstruments2023-04-3011925469ns5:Non-currentFinancialInstruments2022-04-3011925469ns5:ShareCapital2023-04-3011925469ns5:ShareCapital2022-04-3011925469ns5:SharePremium2023-04-3011925469ns5:SharePremium2022-04-3011925469ns5:RetainedEarningsAccumulatedLosses2023-04-3011925469ns5:RetainedEarningsAccumulatedLosses2022-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3011925469ns5:PatentsTrademarksLicencesConcessionsSimilar2022-05-012023-04-3011925469ns5:PlantMachinery2022-05-012023-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2022-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2023-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2022-04-3011925469ns5:PlantMachinery2022-04-3011925469ns5:PlantMachinery2023-04-3011925469ns5:PlantMachinery2022-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-05-012023-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-04-3011925469ns5:AdditionsToInvestments2023-04-3011925469ns5:CostValuation2023-04-3011925469ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3011925469ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-04-3011925469ns5:CurrentFinancialInstruments2022-05-012023-04-3011925469ns10:OrdinaryShareClass12023-04-30
REGISTERED NUMBER: 11925469 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH APRIL 2023

FOR

REGENALL LIMITED

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


REGENALL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30TH APRIL 2023







DIRECTORS: Mr. W Buchanan
Ms. N K C Horlick
Professor C B D Lavy
Mr. H M H Noordeen
Mr. A H Pakravan
Mr R D L P Beresford
Professor A De Silva
Professor R Smith





REGISTERED OFFICE: 19 Harley Street
London
W1G 9QJ





REGISTERED NUMBER: 11925469 (England and Wales)






REGENALL LIMITED (REGISTERED NUMBER: 11925469)

BALANCE SHEET
30TH APRIL 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 217,033 246,321
Tangible assets 5 47,123 63,255
Investments 6 1,507 -
265,663 309,576

CURRENT ASSETS
Debtors 7 53,029 79,971
Cash at bank 597 11,151
53,626 91,122
CREDITORS
Amounts falling due within one year 8 406,499 158,306
NET CURRENT LIABILITIES (352,873 ) (67,184 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(87,210

)

242,392

CREDITORS
Amounts falling due after more than one year 9 104,228 26,320
NET (LIABILITIES)/ASSETS (191,438 ) 216,072

CAPITAL AND RESERVES
Called up share capital 10 14,911 14,831
Share premium 1,130,100 930,179
Retained earnings (1,336,449 ) (728,938 )
SHAREHOLDERS' FUNDS (191,438 ) 216,072

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29th July 2024 and were signed on its behalf by:



Mr. H M H Noordeen - Director


REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2023


1. STATUTORY INFORMATION

Regenall Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2023


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1st May 2022
and 30th April 2023 292,883
AMORTISATION
At 1st May 2022 46,562
Charge for year 29,288
At 30th April 2023 75,850
NET BOOK VALUE
At 30th April 2023 217,033
At 30th April 2022 246,321

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st May 2022
and 30th April 2023 74,418
DEPRECIATION
At 1st May 2022 11,163
Charge for year 16,132
At 30th April 2023 27,295
NET BOOK VALUE
At 30th April 2023 47,123
At 30th April 2022 63,255

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2023


5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1st May 2022
and 30th April 2023 52,108
DEPRECIATION
At 1st May 2022 7,816
Charge for year 6,644
At 30th April 2023 14,460
NET BOOK VALUE
At 30th April 2023 37,648
At 30th April 2022 44,292

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 1,507
At 30th April 2023 1,507
NET BOOK VALUE
At 30th April 2023 1,507

The company has the following unpaid investments in subsidiaries at year end.

-Regenall Phytoceutical Limited (incorporated on 10/08/2021) - 50,000 of 100,000 ordinary shares at £0.01 - £500
-Serendipity Animal Health Limited (incorporated on 11/03/2021; DISSOLVED on 17/10/2023) - 735 of 1000 ordinary shares at £0.01 - £7.35
-Regenall Cosmetics Limited (incorporated on 22/03/2021; DISSOLVED on 17/10/2023) - 1 of 2 ordinary shares at £0.01 - £0.01
-Regenall Equine Health Solutions Limited (incorporated on 08/11/2022) - 100,000 of 100,000 ordinary shares at £.01 - £1,000

Some of the investments above were made in the year ending April 2021 and April 2022 but not recognised in the accounts. The amounts of these investments are not material therefore the accounts in the previous periods will not be restated.

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 53,029 79,971

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2023


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Hire purchase contracts 18,936 15,780
Trade creditors 106,183 65,511
Taxation and social security 9,027 155
Other creditors 272,353 76,860
406,499 158,306

Included in the Other creditors figure are the following:

- A company with a common director/shareholder had a total receivable of £118,772 (2022: £23,667) from Regenall Limited as at 30th April 2023. This balance is interest free and unsecured.

-As at 30th April 2023 there was a balance of £146,574 due to a director/shareholder of Regenall Limited.

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Hire purchase contracts 4,228 26,320
Other creditors 100,000 -
104,228 26,320

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1,941,125 Ordinary £0.01 14,911 14,831

8,000 Ordinary shares of £0.01 each were allotted as fully paid at a premium of £24.99 per share during the year.

11. RELATED PARTY DISCLOSURES

- Polo Breeding Limited a company raising horses and other equines had trading of £15,500 with Regenall Limited during the year. Regenall Limited and Polo Breeding Limited have common shareholders.

- A company with a common director/shareholder had a total receivable of £118,772 (2022: £23,667) from Regenall Limited as at 30th April 2023. This balance is interest free and unsecured.

-As at 30th April 2023 there was a balance of £146,574 due to a director/shareholder of Regenall Limited.